VSee Health

VSEE

Market cap $8.12M

SAN JOSE, CA / ACCESS Newswire / October 17, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leader in telehealth solutions, reported its financial results for the three months ended June 30, 2025 ("Second Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2024 ("Second Quarter 2024").

SAN JOSE, CA / ACCESS Newswire / September 24, 2025 / VSee Health, Inc . (Nasdaq: VSEE) (the "Company"), a provider of comprehensive telehealth services that customizes telehealth work-flow streams and enhances patient care, today announced that the Company was notified by The Nasdaq Stock Market LLC ("Nasdaq") in a letter dated September 15, 2025, that the Nasdaq Hearings Panel (the "Panel") had granted the Company's request for continued listing on Nasdaq, subject to the Company (i) evidencing compliance with Nasdaq's periodic reporting requirement by filing its Q1 and Q2 Quarterly report ending March 31, 2025 and June 30, 2025 respectively (together, the "Delayed Reports") on Form 10-Q by October 15, and (ii) demonstrating compliance with the Equity Rule by December 1, 2025.

SAN JOSE, CALIFORNIA / ACCESS Newswire / September 2, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leader in telehealth solutions, today announced the expansion implementation of 17/of 25 teleradiology. VSee health was awarded an increase to 22 hospitals by a significant vendor who recently awarded an additional 3 hospitals.

SAN JOSE, CA / ACCESS Newswire / August 12, 2025 / VSee Health, Inc. (Nasdaq:VSEE) (the "Company"), a leader in telehealth solutions, today announced that it has requested a hearing before a Nasdaq Listing Qualifications Panel to appeal an earlier Staff Determination to delist the Company's common stock from the Nasdaq Capital Market. VSee Health received a letter from the Nasdaq Stock Market ("Nasdaq") on August 5th, 2025 indicating that the Company did not comply with the NASDAQ's filing requirements because it had not filed its Annual Report on Form 10-K for period ending December 31, 2024, and its Quarterly Report on Form 10-Q for the period ending March 31, 2025.

SAN JOSE, Calif.--(BUSINESS WIRE)-- #AIinHealthcare--VSee's new AI SOAP Notes is transforming emergency telemedicine care, reducing clinical documentation time by 93% per virtual visit.

SAN JOSE, Calif.--(BUSINESS WIRE)-- #AIinHealthcare--VSee's new AI SOAP Notes is transforming emergency telemedicine care, reducing clinical documentation time by 93% per virtual visit.

SAN JOSE, Calif.--(BUSINESS WIRE)-- #clinicaltrial--VSee Health, Inc. (Nasdaq: VSEE) a leading provider of HIPAA-compliant digital health solutions has been selected to support a NIH-funded Phase 3 clinical trial study on stroke recovery telerehabilitation based out of UCLA—the second such national trial of post-stroke telerehabilitation. The trial spans 29 hospitals and 202 patients, and will evaluate the outcomes of adding 6 weeks of gamified, home-based telerehab to improve arm functionality in stroke surviv.

SAN JOSE, Calif.--(BUSINESS WIRE)--VSee Health, Inc. (the “Company”) (Nasdaq: VSEE), announced today that on May 23, 2025, the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company had not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2025, and its Annual Report on Form 10-K for the period ended December 31, 2024, the Company is not in compliance with Nasdaq's listing rule 5250(c)(1), which requires timely filing of p.

SAN JOSE, Calif.--(BUSINESS WIRE)-- #AIinHealthcare--VSee Health, Inc. (Nasdaq: VSEE), a leader in digital health solutions, customized virtual health workflow integration, and real-time health data analytics, announces the launch of Project MAMA (Mom's AI for Maternity Aid), an innovative telehealth initiative to reduce high maternal mortality rates in rural, isolated Philippines communities of Zamboanga Sibugay. Working with maternal care physicians and specialists from Stanford University and Ateneo de Zamboa.

SAN JOSE, Calif.--(BUSINESS WIRE)--VSee Health, Inc. (the “Company”) (Nasdaq: VSEE), announced today that on April 25, 2025, the Company received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company had not yet filed its Annual Report on Form 10-K for the year ended December 31, 2024 (the “Form 10-K”), the Company is not in compliance with Nasdaq's listing rule 5250(c)(1), which requires timely filing of periodic financial reports with the Securities and Exchang.